"The U.S. Food and Drug Administration today approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis.
Current tests used to diagnose gastroparesis "...
Prochlorperazine 25mg suppositories are indicated in the control of severe nausea and vomiting in adults.
DOSAGE AND ADMINISTRATION
Adults: Dosage should be increased more gradually in debilitated or emaciated patients. Elderly Patients: In general, dosages in the lower range are sufficient for most elderly patients. Since they appear to be more susceptible to hypotension and neuromuscular reactions, such patients should be observed closely. Dosage should be tailored to the individual, response carefully monitored and dosage adjusted accordingly. Dosage should be increased more gradually in elderly patients.
To Control Severe Nausea and Vomiting: Adjust dosage to the response of the individual.Begin with the lowest recommended dosage.
Rectal Dosage: 25mg twice daily.
Compro™ Prochlorperazine Suppositories, USP 25mg (for adults) are easy to open, and available in boxes of 12.
12's - NDC 0574-7226-12
Store between 15° and 30°C (59° and 86°F).
Do not remove from wrapper until ready to use. 124140 (06-99)
Paddock Laboratories 1-800-328-5113. Paddock Laboratories Inc, Minneapolis, MN 55427. FDA Rev date:This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/13/2008
Additional Compro Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.